VISTAGEN THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 202.33 million shares for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-02-10
- VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 202.33M shares, a 149.52% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 193.23M shares, a 188.04% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 189.92M shares, a 270.07% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 145.97M shares, a 209.94% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 86.13M shares, a 96.34% increase from fiscal 2020.
- VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 43.87M shares, a 53.59% increase from fiscal 2019.
- VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 28.56M shares, a 105.63% increase from fiscal 2018.
- VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 13.89M shares, a 84.42% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | 202.33M shares 10-Q · filed 2022-02-10 | 197.78M shares derived: average of 2 quarters · filed 2022-02-10 | 195.18M shares 10-Q · filed 2022-02-10 | 182.86M shares derived: average of 4 quarters · filed 2022-02-10 | |
| 2021-09-30 | 193.23M shares 10-Q · filed 2021-11-10 | 191.59M shares 10-Q · filed 2021-11-10 | 176.37M shares derived: average of 3 quarters · filed 2021-11-10 | 152.55M shares derived: average of 4 quarters · filed 2022-02-10 | |
| 2021-06-30 | 189.92M shares 10-Q · filed 2021-08-12 | 167.95M shares derived: average of 2 quarters · filed 2021-08-12 | 138.99M shares derived: average of 3 quarters · filed 2022-02-10 | 121.01M shares derived: average of 4 quarters · filed 2022-02-10 | |
| 2021-03-31 | 145.97M shares 10-K · filed 2021-06-29 | 113.53M shares derived: average of 2 quarters · filed 2022-02-10 | 98.05M shares derived: average of 3 quarters · filed 2022-02-10 | 86.13M shares 10-K · filed 2021-06-29 | |
| 2020-12-31 | 81.09M shares 10-Q · filed 2022-02-10 | 74.08M shares derived: average of 2 quarters · filed 2022-02-10 | 66.55M shares 10-Q · filed 2022-02-10 | 61.65M shares derived: average of 4 quarters · filed 2022-02-10 | |
| 2020-09-30 | 67.08M shares 10-Q · filed 2021-11-10 | 59.25M shares 10-Q · filed 2021-11-10 | 55.17M shares derived: average of 3 quarters · filed 2021-11-10 | 52.16M shares derived: average of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | 51.32M shares 10-Q · filed 2021-08-12 | 49.21M shares derived: average of 2 quarters · filed 2021-08-12 | 47.19M shares derived: average of 3 quarters · filed 2021-08-12 | 46.05M shares derived: average of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | 47.09M shares 10-K · filed 2021-06-29 | 45.13M shares derived: average of 2 quarters · filed 2021-06-29 | 44.29M shares derived: average of 3 quarters · filed 2021-06-29 | 43.87M shares 10-K · filed 2021-06-29 | |
| 2019-12-31 | 43.16M shares 10-K · filed 2021-06-29 | 42.89M shares derived: average of 2 quarters · filed 2021-06-29 | 42.80M shares 10-Q · filed 2021-02-11 | 40.88M shares derived: average of 4 quarters · filed 2021-06-29 | |
| 2019-09-30 | 42.62M shares 10-K · filed 2021-06-29 | 42.62M shares 10-Q · filed 2020-11-12 | 40.12M shares derived: average of 3 quarters · filed 2021-06-29 | 37.76M shares derived: average of 4 quarters · filed 2021-06-29 | |
| 2019-06-30 | 42.62M shares 10-K · filed 2021-06-29 | 38.87M shares derived: average of 2 quarters · filed 2021-06-29 | 36.14M shares derived: average of 3 quarters · filed 2021-06-29 | 33.56M shares derived: average of 4 quarters · filed 2021-06-29 | |
| 2019-03-31 | 35.11M shares 10-K · filed 2020-06-29 | 32.91M shares derived: average of 2 quarters · filed 2020-06-29 | 30.54M shares derived: average of 3 quarters · filed 2020-06-29 | 28.56M shares 10-K · filed 2020-06-29 | |
| 2018-12-31 | 30.70M shares 10-K · filed 2020-06-29 | 28.26M shares derived: average of 2 quarters · filed 2020-06-29 | 26.42M shares 10-Q · filed 2020-02-13 | 25.59M shares derived: average of 4 quarters · filed 2020-06-29 | |
| 2018-09-30 | 25.82M shares 10-K · filed 2020-06-29 | 24.27M shares 10-Q · filed 2019-11-07 | 23.89M shares derived: average of 3 quarters · filed 2020-06-29 | 21.39M shares derived: average of 4 quarters · filed 2020-06-29 | |
| 2018-06-30 | 22.99M shares 10-K · filed 2020-06-29 | 22.93M shares derived: average of 2 quarters · filed 2020-06-29 | 19.92M shares derived: average of 3 quarters · filed 2020-06-29 | 17.41M shares derived: average of 4 quarters · filed 2020-06-29 | |
| 2018-03-31 | 22.88M shares 10-K · filed 2019-06-25 | 18.39M shares derived: average of 2 quarters · filed 2019-06-25 | 15.56M shares derived: average of 3 quarters · filed 2019-06-25 | 13.89M shares 10-K · filed 2019-06-25 | |
| 2017-12-31 | 13.90M shares 10-K · filed 2019-06-25 | 11.89M shares derived: average of 2 quarters · filed 2019-06-25 | 10.95M shares 10-Q · filed 2019-02-12 | 10.36M shares derived: average of 4 quarters · filed 2019-06-25 | |
| 2017-09-30 | 9.89M shares 10-K · filed 2019-06-25 | 9.47M shares 10-Q · filed 2018-10-29 | 9.18M shares derived: average of 3 quarters · filed 2019-06-25 | 8.98M shares derived: average of 4 quarters · filed 2019-06-25 | |
| 2017-06-30 | 9.03M shares 10-K · filed 2019-06-25 | 8.82M shares derived: average of 2 quarters · filed 2019-06-25 | 8.67M shares derived: average of 3 quarters · filed 2019-06-25 | 8.52M shares derived: average of 4 quarters · filed 2019-06-25 | |
| 2017-03-31 | 8.60M shares 10-K · filed 2018-06-26 | 8.49M shares derived: average of 2 quarters · filed 2018-06-26 | 8.34M shares derived: average of 3 quarters · filed 2018-06-26 | 7.53M shares 10-K · filed 2018-06-26 | |
| 2016-12-31 | 8.38M shares 10-K · filed 2018-06-26 | 8.21M shares derived: average of 2 quarters · filed 2018-06-26 | 7.18M shares 10-Q · filed 2018-02-12 | 5.91M shares derived: average of 4 quarters · filed 2018-06-26 | |
| 2016-09-30 | 8.05M shares 10-K · filed 2018-06-26 | 8.04M shares 10-Q · filed 2016-11-14 | 6.58M shares 10-Q · filed 2017-11-09 | 5.09M shares derived: average of 3 quarters · filed 2018-06-26 | 4.26M shares derived: average of 4 quarters · filed 2018-06-26 |
| 2016-06-30 | 5.10M shares 10-K · filed 2018-06-26 | 3.61M shares derived: average of 2 quarters · filed 2018-06-26 | 3.00M shares derived: average of 3 quarters · filed 2018-06-26 | 2.65M shares derived: average of 4 quarters · filed 2018-06-26 | |
| 2016-03-31 | 2.12M shares 10-K · filed 2017-06-29 | 1.94M shares derived: average of 2 quarters · filed 2017-06-29 | 1.84M shares derived: average of 3 quarters · filed 2017-06-29 | 1.77M shares 10-K · filed 2017-06-29 | |
| 2015-12-31 | 1.77M shares 10-K · filed 2017-06-29 | 1.70M shares derived: average of 2 quarters · filed 2017-06-29 | 1.65M shares 10-Q · filed 2017-02-13 | ||
| 2015-09-30 | 1.62M shares 10-K · filed 2017-06-29 | 1.59M shares 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | 1.56M shares 10-K · filed 2017-06-29 | ||||
| 2014-06-30 | 1.23M shares 10-Q · filed 2015-08-14 | ||||
| 2013-09-30 | 21.63M shares 10-Q · filed 2013-11-14 | 21.23M shares 10-Q · filed 2013-11-14 | |||
| 2012-09-30 | 17.09M shares 10-Q · filed 2013-11-14 | 16.97M shares 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |